Results 191 to 200 of about 63,206 (209)

Tenofovir

Reactions Weekly, 2008
openaire   +2 more sources

Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV

New England Journal of Medicine, 2019
Willem Venter, Michelle A Moorhouse, Simiso Sokhela   +2 more
exaly  

Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women

Science, 2017
Nichole R Klatt, Kenzie Birse, Alexander S Zevin   +2 more
exaly  

Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial

Lancet, The, 2017
Adriano Lazzarin, Chloe Orkin, Daniel Podzamczer   +2 more
exaly  

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks

Lancet, The, 2012
Paul E Sax, Anthony M Mills
exaly  

Birth Outcomes for Pregnant Women with HIV Using Tenofovir–Emtricitabine

New England Journal of Medicine, 2018
Kathryn Rough, ScD, Sonia Hernandez-Diaz, Kunjal Patel   +2 more
exaly  

Tenofovir

Reactions Weekly, 2021
openaire   +1 more source

Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women

Nature Medicine, 2018
Lyle R Mckinnon, Derseree Archary, Sinaye Ngcapu   +2 more
exaly  

Tenofovir

Reactions Weekly, 2023
openaire   +1 more source

Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load

New England Journal of Medicine, 2016
Calvin Q Pan, Zhongping Duan
exaly